Advanced Drug Delivery Nanosystems: Perspectives and Regulatory Issues

被引:6
|
作者
Demetzos, Costas [1 ]
机构
[1] Univ Athens, Fac Pharm, Dept Pharmaceut Technol, GR-15771 Athens, Greece
来源
关键词
Advanced Drug Delivery nano Systems (aDDnSs); Nanotechnology; Controlled release; BIOLOGICAL MEDIA; ADDNSS;
D O I
10.1007/978-3-319-08927-0_22
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This chapter deals with the classification of Drug Delivery nano Systems (DDnSs) with a Modulatory Controlled Release profile (MCR) denoted as Modulatory Controlled Release nano Systems (MCRnSs). Conventional (c) and advanced (a) DDnSs are denoted by the acronyms cDDnSs and aDDnSs, and can be composed of a single or more than one biomaterials, respectively. The classification was based on their characteristics such as surface functionality (f), the nature of biomaterials used, and the kind of interactions between biomaterials. The aDDnSs can be classified as Hybridic (Hy-) or Chimeric (Chi-) based on the nature-same or different, respectively-of biomaterials and inorganic materials used. The nature of the elements used for producing advanced biomaterials is of great importance and medicinal chemistry contributes effectively to the production of aDDnSs.
引用
收藏
页码:195 / 198
页数:4
相关论文
共 50 条
  • [21] Development of micro- and nanosystems for drug delivery
    N. I. Larionova
    D. Duchêne
    P. Couvreur
    M. Ollivon
    R. Gref
    Russian Journal of General Chemistry, 2008, 78 : 2220 - 2229
  • [22] Smart Supramolecular Nanosystems for Bioimaging and Drug Delivery
    Yang, Peipei
    Wang, Lei
    Wang, Hao
    CHINESE JOURNAL OF CHEMISTRY, 2015, 33 (01) : 59 - 70
  • [23] Programmed drug delivery: nanosystems for tumor targeting
    Wagner, Ernst
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (05) : 587 - 593
  • [24] Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy
    Mohajer, Fatemeh
    Ziarani, Ghodsi Mohammadi
    Badiei, Alireza
    Iravani, Siavash
    Varma, Rajender S.
    MICROMACHINES, 2022, 13 (10)
  • [25] Regulatory and legal issues in development of controlled drug delivery products.
    Chan, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U432 - U432
  • [26] SMART INTEGRATED NANOSYSTEMS FOR BIOMEDICAL APPLICATIONS: CRITICAL ISSUES AND PERSPECTIVES
    Lombardo, Domenico
    Pasqua, Luigi
    Kiselev, Mikhail A.
    ATTI ACCADEMIA PELORITANA DEI PERICOLANTI-CLASSE DI SCIENZE FISICHE MATEMATICHE E NATURALI, 2019, 97
  • [27] NOCANTHER: GMP scale up for Drug Delivery nanosystems
    Ibarrola Moreno, O.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S54 - S54
  • [28] Nanosystems for simultaneous imaging and drug delivery to T cells
    Tarke M. Fahmy
    Peter M. Fong
    Jason Park
    Todd Constable
    W. Mark Saltzman
    The AAPS Journal, 9
  • [29] Potential drug delivery nanosystems for improving tumor penetration
    Peng, Feifei
    Li, Ruirui
    Zhang, Fang
    Qin, Li
    Ling, Guixia
    Zhang, Peng
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 151 : 220 - 238
  • [30] Cyclodextrin nanosystems in oral drug delivery: A mini review
    Adeoye, Oluwatomide
    Cabral-Marques, Helena
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 531 (02) : 521 - 531